Pakistan drugmakers need Govt action on DRA says PPMA
Drugmakers in Pakistan are suffering and parliament needs to implement on the proposed Drug Regulatory Authority (DRA) according to the Pakistan Pharmaceutical Manufacturers Association (PPMA).
Archives for October 2, 2012
update
Apax’s Marken dealmaker quits calling the investment a ‘tough one’
The Mann who bought Marken for investment group Apax Partners has stepped down, describing the deal for the logistics contractor as one of the ‘tough ones’.
EMA will accept reference meds made outside Europe under biosimilars guidelines
The EMA plans to accept reference medicines sourced from outside the European Economic Area (EEA) under its updates biosimilar guidance.
Medichem passes FDA inspection for 2nd time this year
A manufacturing plant operated by Spanish API maker Medichem has passed an inspection by the US FDA for the fifth time in a row.
ChemAxon opens Boston HQ in face of growing US demand
ChemAxon has opened a US headquarters to boost its technical, scientific and consultancy services.
Catalent and Parexel team up to offer clinical trial material supply services
Catalent and Parexel have teamed up to offer clinical trial material supply services.
QPS Qualitix sets up Beijing office
CRO QPS Qualitix has continued its expansion in Asia with a new office in China.